Interestingly, all these phenomena were not related to the pro-autophagy functions of AMBRA, thus suggesting the existence of compensatory events and a new therapeutic strategy proposing FAK1 inhibition for AMBRA1 low-expressing melanoma [143]. Here, PTK2 is linked to melanoma.